<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <title>Conflicts of Interest</title>
 <p>R.A. received consultancy or speakersâ€™ fees from UCB, Sandoz, Abbvie, Zentiva, Teva, Laropharm, CEGEDIM, Angelini, Biessen Pharma, Hofigal, AstraZeneca, and Stada. All other authors report no conflict of interest.</p>
</notes>
